BCRX BioCryst Pharmaceuticals Inc

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is a late clinical stage biotech firm that focuses on oral drugs for the treatment of rare and serious diseases. The company was founded in 1986 and first listed on the Nasdaq in 1994. Since listing, BCRX shares have endured a wild ride of cycles roughly every 5 years. The cyclical […]
https://www.valuewalk.com/biocryst-receives-fast-track-designation-for-alk-2-inhibitor-bcx9250/